Slide 1: Powering what comes next.
S O L I D - S T A T E M IC R O B A T T E R I E S Powering what comes next. Q2 Investor Presentation Shauna McIntyre Bryce Dille CEO CFO
Slide 2: Forward-looking statement.
August 2026 Forward-looking statement. This presentation includes “forward-looking” statements, including, Readers and prospective investors of the Group’s shares are cautioned without limitation, projections and expectations regarding Ensurge and that Forward-looking Statements are not guarantees o
Slide 3: 2026: On the path to commercialization
August 2026 2026: On the path to commercialization Q1 2026 Q2 2026 H2 2026 Product Process External Performance Repeatability Customer Validation ✓ Record multi-layer cycle life and capacity retention ✓ Commercial: Recruited Chief Commercial Officer; ❑ Convert customer engagements into paid long- ✓
Slide 4: Q2 2026 achievements
August 2026 Q2 2026 achievements Positioning Ensurge for its next phase: expert leadership, commercial traction, disciplined cost efficiency, and product excellence Commercial Financials Team Product & Technology • Paid customer development • San Jose relocation to deliver USD • Bryce Dille, CFA app
Slide 5: From record performance in Q1 onto reproducibility in Q2
T ECHN OLOGY August 2026 From record performance in Q1 onto reproducibility in Q2 Resolving key component process variability unlocks manufacturing, scale and commercialization • Objectives defined: LiPON sputtering specification set for 4x required composition and conductivity. • Process assessed:
Slide 6: Value is in the stack, and LiPON is the critical enabler
Value is in the stack, and LiPON is the critical enabler A stable, pin-hole free electrolyte withstands high-temp processing and carries the stack across both Ensurge platforms BASELINE R&D PLATFORM ENCORE PRODUCT PLATFORM (Stainless Steel Substrate) (Corning Ribbon Ceramic Cathode) LEA RN I NGS A P
Slide 7: Q1: Record multi-layer cycle life and capacity retention
H1 2026 PER FORM A NCE · DA TA E ST ABLISHE D IN Q 1 2 0 26 August 2026 Q1: Record multi-layer cycle life and capacity retention Over 100 cycles at 80% capacity retention and over 200 cycles at 70%, an accepted threshold for an emerging chemistry. Proof-of-Concept target of 250+ cycles now within Si
Slide 8: Product status
August 2026 Product status New Product Introduction Accomplished Today’s Focus DI SCOVE RY ENGINEERING Innovation Proof of Concept Engineering Validation Design Validation Production Validation Mass Production Technical feasibility Initial prototype testing Final product testing Pilot production Ful
Slide 9: A product built to win the 1–100 mAh window
A product built to win the 1–100 mAh window In partnership with Corning, Ensurge introduces a new class of solid-state microbattery that maximizes volumetric energy density Energy Density 1000 Volumetric energy density (Wh/l) Unbeatable pack-level energy density 800 600 Safety 400 No flammable liqui
Slide 10: Microbattery TAM 1–100 mAh range $19B
Earbuds | rings | watches S egm ents in ac tiv e 25.0% disc ussi on MIC ROBAT TERY TAM 2032 1–100 mAh RANGE +$4B+ Wearables $0.3B $2.1B+ Growing 24%+ CAGR through Patches | implants | hearing aids $19B 2032, stranded between sub- 24.2% mAh solid-state and traditional Li-ion, with no volume supplier.
Slide 11: Market validation creates a compelling opportunity
August 2026 Market validation creates a compelling opportunity Technology Benchmark Market Proof Points Metric Competitor ASSB1 Ensurge ASSB Targets Commercial adoption 01 Wireless cooking Voltage range 2.6-4.0 V 3.0-4.2 V temperature sensor Nominal voltage 2.3 V 3.6 V Form-factor expansion 02 ER-si
Slide 12: Relocating San Jose operations
C OST STR UC TURE August 2026 Relocating San Jose operations Showcase facility 96,000 sq ft → 32,000 sq ft Purpose-built battery pilot line Customer-ready site for partners Planned transition for seamless transfer >USD 3.5M of recurring annual savings, on completion (70% reduction) ~30% → ~10% Reduc
Slide 13: Q2 2026 financials
August 2026 Q2 2026 financials USD thousand Q2 25 Q1 26 Q2 26 Revenue and other income of USD 3 thousand in Q2 26, and USD 157 thousand in H1 26, from strategic Revenue and other income 0 154 3 development and partnership activities Operating expenditure incl. 4,277 4,082 4,396 capitalized R&D Opera
Slide 14: Outlook: second half priorities
August 2026 Outlook: second half priorities H1 2026 H2 2026 Delivered in the first half: ✓ Record performance established, then reproduced outside the glove box ✓ 4x improvement in core technological differentiator, solid-state LiPON Product Commercial Financials electrolyte process repeatability ✓
Slide 15: Powering what comes next.
Powering what comes next. A NEW C A TEGORY OF BATTERY For a new generation of devices.